Loading insider details...
Latest Form 4 (Sep 4, 2026): Grant/Award of 17,000 PLX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 4, 2026 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 17,000 | n/a |
| Sep 4, 2025 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 7,500 | n/a |